Related Experiment Video
Updated: Apr 25, 2026

Modeling Chemotherapy Resistant Leukemia In Vitro
Published on: February 9, 2016
[Silence potentiates chemosensitivity of K562 cells to SAHA]
Hou-Cai Wang1, Jing Chen1, Na An1
1State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Disease Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Abstract:
Ribosomal protein S27a (RPS27a) can perform extra-ribosomal functions besides imparting a role in ribosome biogenesis and post-translational modifications of proteins. The RPS27a gene has been reported to be over-expressed in breast fibroadenomas, colorectal and renal cancers, advanced-phase chronic myeloid leukemia (CML) and acute leukemia (AL) patients. This study was purposed to explore the function of RPS27a in CML-erythroleukemia cell line K562 cells. RPS27a was silenced by short hairpin RNA (shRNA) in K562 cells. Furthermore, the proliferation changes of K562 cells was detected by MTT method after silencing the RPS27a with suberoylanilide hydroxamic acid (SAHA), then the IC50 of K562-sh1/sh2 and K562-scr cells to SAHA was measured. The results indicated that compared with K562-scr cells, the IC50 of K562-sh1/sh2 to SAHA at 24 h and 48 h decreased (P < 0.01); RPS27a silence significantly increased the percentage of apoptotic K562-sh1/sh2 cells after incubation with 1 µmol/L, 2 µmol/L and 5 µmol/L SAHA for 24 h and 48 h as compared with that of K562-scr cells (P < 0.01). K562-sh1, K562-sh2 and K562-scr cells after incubation with or without 2 µmol/L SAHA for 48 h presented apoptosis features: i. e. chromatin condensation, nucleic fragmentation and apoptotic body formation. It is concluded that RPS27a can inhibit the apoptosis of K562 cells and RPS27a silence can potentiate sensitivity of K562 cells to SAHA.
Insights
Ribosomal protein S27a (RPS27a) inhibits apoptosis in chronic myeloid leukemia cells. Silencing RPS27a enhances K562 cell sensitivity to SAHA, increasing apoptosis and impacting cancer treatment strategies.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- Ribosomal protein S27a (RPS27a) has known extra-ribosomal roles.
- RPS27a is over-expressed in various cancers, including leukemia.
- Its specific function in chronic myeloid leukemia (CML) requires further investigation.
Purpose of the Study:
- To investigate the role of RPS27a in K562 CML cells.
- To determine the effect of RPS27a silencing on K562 cell proliferation and apoptosis.
- To assess the impact of RPS27a on sensitivity to suberoylanilide hydroxamic acid (SAHA).
Main Methods:
- Short hairpin RNA (shRNA) was used to silence RPS27a in K562 cells.
- Cell proliferation was assessed using the MTT assay.
- Apoptosis was quantified by flow cytometry and morphological analysis after SAHA treatment.
Main Results:
- RPS27a silencing decreased the IC50 of K562 cells to SAHA.
- Silencing RPS27a significantly increased SAHA-induced apoptosis in K562 cells.
- Morphological changes indicative of apoptosis were observed in silenced cells upon SAHA treatment.
Conclusions:
- RPS27a inhibits apoptosis in K562 CML cells.
- RPS27a knockdown potentiates the sensitivity of K562 cells to SAHA.
- Targeting RPS27a may represent a therapeutic strategy to enhance leukemia treatment efficacy.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Treatment Resistant Cancers

